Drug intelligence / Profile preview

niuhuang qinggan

Development stage
Unknown
Lead developer
Second Affiliated Hospital of Heilongjiang University of Chinese Medicine
Administration
Oral
01

Overview

Niuhuang Qinggan is a Traditional Chinese Medicine (TCM) formulation, typically administered in capsule form, used for the treatment of the common cold, specifically the wind-heat syndrome. The formulation is designed to clear heat and detoxify the body. It has been evaluated in clinical trials, such as ChiCTR2200055642, which was a randomized, double-blind, parallel-controlled, multi-center trial for Chinese medicine variety protection. This trial compared the Niuhuang Qinggan Capsule to the Shufeng Jiedu Capsule to assess its efficacy and safety in patients with the common cold. The development and clinical evaluation of this drug have been sponsored by institutions such as The Second Affiliated Hospital of Heilongjiang University of Traditional Chinese Medicine.

Brand names
Niuhuang Qinggan Capsule
Other names
Niuhuang Qinggan Jiao-nangNiuhuang Qinggan Jiaonang
02

Targets

NFE2L2 (Nuclear factor (erythroid-derived 2)-like 2)NF-κB

Beyond the preview

Go deeper on niuhuang qinggan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on niuhuang qinggan.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call